Yousif Capital Management, LLC Xencor Inc Transaction History

Yousif Capital Management, LLC

  • $8.96 Billion
  • Q3 2024

A detailed history of Yousif Capital Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 19,032 shares of XNCR stock, worth $458,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,032
Previous 19,702 3.4%
Holding current value
$458,671
Previous $372,000 2.69%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$15.7 - $21.65 $10,519 - $14,505
-670 Reduced 3.4%
19,032 $382,000
Q2 2024

Jul 31, 2024
SELL
$18.21 - $24.5 $46,708 - $62,842
-2,565 Reduced 11.52%
19,702 $372,000
Q1 2024

Apr 26, 2024
SELL
$18.65 - $26.52 $49,981 - $71,073
-2,680 Reduced 10.74%
22,267 $492,000
Q4 2023

Feb 01, 2024
SELL
$16.53 - $21.42 $18,711 - $24,247
-1,132 Reduced 4.34%
24,947 $529,000
Q3 2023

Oct 30, 2023
SELL
$20.08 - $25.39 $41,425 - $52,379
-2,063 Reduced 7.33%
26,079 $525,000
Q2 2023

Aug 02, 2023
SELL
$24.77 - $29.9 $52,017 - $62,790
-2,100 Reduced 6.94%
28,142 $702,000
Q1 2023

May 02, 2023
SELL
$25.95 - $36.95 $174,435 - $248,377
-6,722 Reduced 18.19%
30,242 $843,000
Q4 2022

Jan 09, 2023
SELL
$24.79 - $30.86 $248,767 - $309,680
-10,035 Reduced 21.35%
36,964 $0
Q3 2022

Nov 04, 2022
SELL
$24.62 - $32.44 $13,294 - $17,517
-540 Reduced 1.14%
46,999 $1.22 Million
Q2 2022

Aug 01, 2022
SELL
$19.74 - $29.01 $116,979 - $171,913
-5,926 Reduced 11.08%
47,539 $1.3 Million
Q1 2022

May 12, 2022
BUY
$26.68 - $41.63 $21,530 - $33,595
807 Added 1.53%
53,465 $1.43 Million
Q4 2021

Jan 31, 2022
BUY
$33.67 - $43.44 $1.77 Million - $2.29 Million
52,658 New
52,658 $2.11 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email